Baxter International, Inc. (BAX)
| Market Cap | 43.20B |
| Revenue (ttm) | 12.45B |
| Net Income (ttm) | 1.21B |
| Shares Out | 500.69M |
| EPS (ttm) | 2.38 |
| PE Ratio | 36.31 |
| Forward PE | 20.37 |
| Dividend | $1.09 (1.26%) |
| Ex-Dividend Date | Dec 2, 2021 |
| Volume | 2,348,357 |
| Open | 86.65 |
| Previous Close | 85.99 |
| Day's Range | 85.51 - 86.82 |
| 52-Week Range | 73.12 - 88.91 |
| Beta | 0.64 |
| Analysts | Buy |
| Price Target | 97.80 (+13.4%) |
| Earnings Date | Feb 17, 2022 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical...
Financial Performance
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is 97.80, which is an increase of 13.35% from the latest price.
News
New Strong Buy Stocks for January 18th
KBH, BAX, F, EGO, and AXS have been added to the Zacks Rank #1 (Strong Buy) List on January 18, 2022.
Best Income Stocks to Buy for January 18th
BAX, F, and WBS made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 18, 2022
Best Momentum Stocks to Buy for January 18th
BAX, F, and EGO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 18, 2022
5 Low-Beta High-Yielding Stocks to Buy in a Capricious Market
We have narrowed our search to five large-cap low-beta stocks with a solid dividend yield. These are: PFE, BAX, IBKR, PSA and CUBE.
New Strong Buy Stocks for January 17th
AXS, BAX, F, UNFI, and BRDG have been added to the Zacks Rank #1 (Strong Buy) List on January 17, 2022.
Here's Why You Should Retain Baxter (BAX) Stock For Now
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.
Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February 17...
4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy
Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.
Alcoa Set to Join S&P MidCap 400
NEW YORK, Dec. 13, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400: Alcoa Corp. (NYSE:AA) will replace Hill-Rom Holdings Inc. (NYSE:HRC) in the S&P MidCa...
Baxter Completes Acquisition of Hillrom, Creating ~$15 Billion Global Medtech Leader
DEERFIELD, Ill.--(BUSINESS WIRE)---- $BAX--Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for eac...
Baxter Presents Data at ASHP Meeting Indicating Machine Learning May Enhance Infusion Pump Programming Safety
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine lear...
4 MedTech Dividend Stocks in Focus on Amid Omicron Variant Panic
Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.
Larry Robbins' Top 5 Trades of the 3rd Quarter
Glenview Capital Management, the firm founded by Larry Robbins (Trades, Portfolio), disclosed in November that its top five trades during the third quarter included a new holding in Willis Towers Watson...
Baxter's (BAX) $100M Investment to Strengthen Global Presence
Baxter's (BAX) strategic investment to help expand the manufacturing footprint of BPS and ensure improvement in products.
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...
Baxter Named to Dow Jones Sustainability Indices in Recognition of Continued Commitment to Corporate Responsibility
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a leading global medical products company, today announced it was again named to the S&P's Dow Jones Sustainability Indices (DJSI...
Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufact...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced a $100M investment in its manufacturing facility in Halle/Westfalen, Germany that will add new capacity and capabilities.
Baxter Highlights New Data Indicating Sharesource Digital Health Platform for Home Dialysis May Improve Survival and ...
DEERFIELD, Ill.--(BUSINESS WIRE)-- #digitalhealth--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing kidney patients may experience a survival rate...
Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 4th Annual HealthCONx Conference on Thursday, December...
Baxter Shares Fall Despite Better-Than-Expected Q3 Earnings, FY21 EPS Outlook Boost
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6% on an operational basis. Adjusted ...
Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates
Baxter's (BAX) third-quarter results reflect robust performance across all its business units.
Baxter International (BAX) Q3 Earnings and Revenues Beat Estimates
Baxter (BAX) delivered earnings and revenue surprises of 8.51% and 0.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Baxter Reports Third-Quarter 2021 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2021. “Baxter's essential products, div...
Baxter (BAX) to Report Q3 Earnings: What's in the Offing?
Baxter's (BAX) third-quarter results are likely to reflect growth in its Acute Therapies business.
Baxter International (BAX) Earnings Expected to Grow: Should You Buy?
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.